Inj Trastzuzumab 300mg,Inj Trastzuzumab 440mg,Inj Trastzuzumab Emtansine 160mg,Inj Carfilzumib 60mg
Directorate Of Health Services Kashmir
BUDGAM, JAMMU & KASHMIR
Progress
RAQuantity
2958
Category
Inj Cetuximab 100 mg
Bid Type
Two Packet Bid
Public procurement opportunity for Employees State Insurance Corporation (esic) Inj Cetuximab 100 mg, NS Glass Bottle 500 ml, NS Glass Bottle 250ml, Inj Methotrexate 50 mg, Inj Degarelix 80 mg, Tab Erlotinib 100 mg, Tab Dasatinib 50 mg, Tab Olaparib 150 mg, Tab Lenvatinib 4mg, Tab Erlotinib 150mg, Tab Celecoxib 200 mg, Buprenorphine Patch 10 mg in AHMEDABAD, GUJARAT. Quantity: 2958 issued by. Submission Deadline: 09-07-2025 10: 00: 00. View full details and respond.
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS
Directorate Of Health Services Kashmir
BUDGAM, JAMMU & KASHMIR
Indian Army
KUPWARA, JAMMU & KASHMIR
Indian Navy
VISAKHAPATNAM, ANDHRA PRADESH
Indian Navy
UTTARA KANNADA, KARNATAKA
Indian Army
Tender Results
Loading results...
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) |
|---|---|---|---|---|---|---|
| 1 | Inj Cetuximab 100 mg | Inj Cetuximab 100 mg | 100 | vial | ihsmhb | 15 |
| 2 | NS Glass Bottle 500 ml | NS Glass Bottle 500 ml | 300 | bottle | ihsmhb | 15 |
| 3 | NS Glass Bottle 250ml | NS Glass Bottle 250ml | 50 | bottle | ihsmhb | 15 |
| 4 | Inj Methotrexate 50 mg | Inj Methotrexate 50 mg | 5 | vial | ihsmhb | 15 |
| 5 | Inj Degarelix 80 mg | Inj Degarelix 80 mg | 3 | vial | ihsmhb | 15 |
| 6 | Tab Erlotinib 100 mg | Tab Erlotinib 100 mg | 500 | tablet | ihsmhb | 15 |
| 7 | Tab Dasatinib 50 mg | Tab Dasatinib 50 mg | 300 | tablet | ihsmhb | 15 |
| 8 | Tab Olaparib 150 mg | Tab Olaparib 150 mg | 300 | tablet | ihsmhb | 15 |
| 9 | Tab Lenvatinib 4mg | Tab Lenvatinib 4mg | 300 | tablet | ihsmhb | 15 |
| 10 | Tab Erlotinib 150mg | Tab Erlotinib 150mg | 500 | tablet | ihsmhb | 15 |
| 11 | Tab Celecoxib 200 mg | Tab Celecoxib 200 mg | 500 | tablet | ihsmhb | 15 |
| 12 | Buprenorphine Patch 10 mg | Buprenorphine Patch 10 mg | 100 | patch | ihsmhb | 15 |
Start
06-Aug-2025, 10:00 am
End
07-Aug-2025, 10:00 am
Duration: 24 hours
Reverse Auction Document
✅ RA concluded. Check financial results for final rankings.
| S.No | Seller | Item | Date | Status |
|---|---|---|---|---|
| 1 | ********** Under PMA | - | 09-07-2025 08:43:39 | Evaluated |
| 2 | ********** Under PMA | - | 08-07-2025 20:08:02 | Evaluated |
| 3 | ********** Under PMA | - | 08-07-2025 19:13:17 | Evaluated |
| 4 | ********** Under PMA | - | 05-07-2025 18:50:35 | Evaluated |
| 5 | ********** Under PMA | - | 08-07-2025 21:00:00 | Evaluated |
| 6 | ********** Under PMA | - | 08-07-2025 18:51:17 | Evaluated |
| 7 | ********** Under PMA | - | 08-07-2025 19:19:15 | Evaluated |
| 8 | ********** Under PMA | - | 08-07-2025 17:39:14 | Evaluated |
Please sign in or create an account to view contract details and download result documents.
Key insights about GUJARAT tender market
The eligibility requirements include being a registered entity with valid certifications for manufacturing and supplying pharmaceutical products. Participants must have a history of similar supply contracts and comply with healthcare regulations.
The technical specifications include demonstrating compliance with Good Manufacturing Practices (GMP) and providing evidence of prior successful supply contracts for chemotherapy products. Valid product registrations as per national guidelines are also essential.
While specific dates are not stated, the submission method requires all bids to be submitted electronically, ensuring adherence to the prescribed formats outlined in the tender portal. Bidders are advised to regularly check for updated guidelines.
Pricing evaluation will prioritize competitiveness while ensuring adherence to quality standards. Bidders must present a transparent financial proposal that aligns with the provided technical documentation and demonstrates value for money.
MSEs may benefit from simplified submission processes and potential financial concessions under the tender provisions, promoting inclusivity and encouraging participation from smaller enterprises in the pharmaceutical sector.
Sign up now to access all documents
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS